News
SVA
6.47
0.00%
0.00
Weekly Report: what happened at SVA last week (0504-0508)?
Weekly Report · 5h ago
Sinovac Posts First-Half 2025 Loss Despite Overseas Vaccine Growth and Special Dividend
TipRanks · 2d ago
Sinovac Biotech H1 Adj. EPS $0.06 Down From $1.18 YoY, Sales $130.270M Up From $128.711M YoY
Benzinga · 2d ago
Sinovac FY25 H1 swings to net loss of $21.7 million; net sales rise 1.21% to $130.3 million
PUBT · 2d ago
Sinovac Biotech Files Form 6-K to Correct Typographical Error in 2024 Annual Report
TipRanks · 4d ago
Sinovac corrects typo in Note 2 sub-numbering in 2024 annual report
PUBT · 4d ago
Weekly Report: what happened at SVA last week (0427-0501)?
Weekly Report · 05/04 10:06
Sinovac Biotech Delays Key Annual 20-F Filing
TipRanks · 04/30 16:44
Sinovac delays filing 2025 annual report after prior-year financial restatements
PUBT · 04/30 14:17
Sinovac FY24 net income drops to $40.7 million; net sales fall 23.1% to $361.4 million
PUBT · 04/30 14:15
Weekly Report: what happened at SVA last week (0420-0424)?
Weekly Report · 04/27 10:08
NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 03:58 AM
Reuters · 04/23 07:58
NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 03:58 AM
Reuters · 04/22 07:58
Weekly Report: what happened at SVA last week (0413-0417)?
Weekly Report · 04/20 10:04
Sinovac Biotech director Li Jiaqiang files initial beneficial ownership statement
PUBT · 04/17 10:10
Weekly Report: what happened at SVA last week (0406-0410)?
Weekly Report · 04/13 10:08
NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 03:58 AM
Reuters · 04/10 07:58
Weekly Report: what happened at SVA last week (0330-0403)?
Weekly Report · 04/06 10:08
Weekly Report: what happened at SVA last week (0323-0327)?
Weekly Report · 03/30 10:08
Weekly Report: what happened at SVA last week (0316-0320)?
Weekly Report · 03/23 10:04
More
Webull provides a variety of real-time SVA stock news. You can receive the latest news about Sinovac Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SVA
Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.